[Cl:1][C:2]1[CH:7]=[CH:6][N:5]=[C:4]([O:8][C:9]2[CH:16]=[CH:15][C:12]([CH:13]=O)=[CH:11][CH:10]=2)[CH:3]=1.[BH4-].[Na+].S(Cl)(Cl)=O.[CH3:23][N:24]1[CH:28]=[C:27]([CH2:29][C:30]2[C:31](=[O:37])[NH:32][C:33](=[S:36])[NH:34][CH:35]=2)[CH:26]=[N:25]1>CO.C(Cl)Cl>[Cl:1][C:2]1[CH:7]=[CH:6][N:5]=[C:4]([O:8][C:9]2[CH:16]=[CH:15][C:12]([CH2:13][S:36][C:33]3[NH:34][CH:35]=[C:30]([CH2:29][C:27]4[CH:26]=[N:25][N:24]([CH3:23])[CH:28]=4)[C:31](=[O:37])[N:32]=3)=[CH:11][CH:10]=2)[CH:3]=1To a solution of 4-[(4-chloro-2-pyridinyl)oxy]benzaldehyde (120 mg, 0.514 mmol), (which may be prepared according to procedures described in the International Patent Application Publication No. WO 199847869) in methanol (2.0 mL) was added NaBH4 (23.32 mg, 0.616 mmol). After the suspended solution turned clear, it was quenched with water. The mixture was extracted with EA and concentrated. After removing the solvent, thionyl chloride (0.187 mL, 2.57 mmol) and DCM (2 mL) was added, and stirring continued overnight. Then 5-[(1-methyl-1H-pyrazol-4-yl)methyl]-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone (114 mg, 0.514 mmol) was added. The reaction mixture was heated at 60° C. for 0.5 h. Purification via MDAP then afforded the title compound (132 mg, 58.4% yield). LCMS: rt=2.84 min, [M+H+]=440